Your browser doesn't support javascript.
loading
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant.
Nikolousis, E; Robinson, S; Nagra, S; Brookes, C; Kinsella, F; Tauro, S; Jeffries, S; Griffiths, M; Mahendra, P; Cook, M; Paneesha, S; Lovell, R; Kishore, B; Chaganti, S; Malladi, R; Raghavan, M; Moss, P; Milligan, D; Craddock, C.
Affiliation
  • Nikolousis E; Department of Haematology, Heart of England NHS Foundation Trust, Birmingham, UK. emelni@hotmail.com
Leuk Res ; 37(5): 561-5, 2013 May.
Article in En | MEDLINE | ID: mdl-23395505
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Transplantation Chimera / Hematologic Neoplasms / Transplantation Conditioning / Stem Cell Transplantation / Antibodies, Monoclonal, Humanized / Graft vs Host Disease / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Transplantation Chimera / Hematologic Neoplasms / Transplantation Conditioning / Stem Cell Transplantation / Antibodies, Monoclonal, Humanized / Graft vs Host Disease / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2013 Document type: Article Affiliation country: Country of publication: